NO138026C - Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner

Info

Publication number
NO138026C
NO138026C NO2303/73A NO230373A NO138026C NO 138026 C NO138026 C NO 138026C NO 2303/73 A NO2303/73 A NO 2303/73A NO 230373 A NO230373 A NO 230373A NO 138026 C NO138026 C NO 138026C
Authority
NO
Norway
Prior art keywords
analogical
piperazines
benzhydryl
hydroxybenzyl
procedures
Prior art date
Application number
NO2303/73A
Other languages
English (en)
Other versions
NO138026B (no
Inventor
Thomas Raabe
Josef Scholtholt
Eckhard Schraven
Rolf-Eberhard Nitz
Original Assignee
Cassella Farbwerke Mainkur Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2226767A external-priority patent/DE2226767A1/de
Priority claimed from DE19732312212 external-priority patent/DE2312212A1/de
Application filed by Cassella Farbwerke Mainkur Ag filed Critical Cassella Farbwerke Mainkur Ag
Publication of NO138026B publication Critical patent/NO138026B/no
Publication of NO138026C publication Critical patent/NO138026C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205Radicals derived from carbonic acid
NO2303/73A 1972-06-02 1973-06-01 Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner NO138026C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2226767A DE2226767A1 (de) 1972-06-02 1972-06-02 N-benzhydryl-n'-p-hydroxybenzylpiperazin und verfahren zu seiner herstellung
DE19732312212 DE2312212A1 (de) 1973-03-12 1973-03-12 N-(p-chlorbenzhydryl)-n'-p-hydroxybenzyl-piperazin und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
NO138026B NO138026B (no) 1978-03-06
NO138026C true NO138026C (no) 1978-06-14

Family

ID=25763357

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2303/73A NO138026C (no) 1972-06-02 1973-06-01 Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner

Country Status (26)

Country Link
US (1) US3868377A (no)
JP (1) JPS4948687A (no)
AR (5) AR194688A1 (no)
AT (3) AT331252B (no)
AU (1) AU470393B2 (no)
BG (3) BG20596A3 (no)
CA (1) CA980347A (no)
CH (4) CH579064A5 (no)
CS (4) CS178430B2 (no)
DD (1) DD106644A5 (no)
DK (1) DK139751C (no)
EG (1) EG11434A (no)
ES (3) ES415466A1 (no)
FI (1) FI55656C (no)
FR (1) FR2186265B1 (no)
GB (1) GB1386916A (no)
HU (1) HU165312B (no)
IE (1) IE37717B1 (no)
IL (1) IL42384A (no)
NL (1) NL7306771A (no)
NO (1) NO138026C (no)
PH (1) PH9485A (no)
PL (3) PL97129B1 (no)
RO (3) RO62900A (no)
SE (1) SE396385B (no)
SU (4) SU507238A3 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59101475A (ja) * 1982-12-02 1984-06-12 Nippon Chemiphar Co Ltd 新規ピペラジン誘導体およびその製造法ならびにこれを含有する脳循環改善剤
HU186656B (en) * 1982-12-28 1985-09-30 Richter Gedeon Vegyeszet Process for producing new benzhydryl-piperazine derivatives, acid additionak salts and pharmaceutical compositions containing them
GB8320701D0 (en) * 1983-08-01 1983-09-01 Wellcome Found Chemotherapeutic agent
JPS60222472A (ja) * 1984-03-30 1985-11-07 Kanebo Ltd 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物
ATE107296T1 (de) * 1988-08-05 1994-07-15 Nippon Chemiphar Co Optisch aktive piperazin-derivate.
FR2661176B1 (fr) * 1990-04-20 1992-06-12 Adir Nouveau procede de preparation de la 1-(2,3,4-trimethoxybenzyl) piperazine en amination reductive.
JP3150155B2 (ja) * 1993-12-08 2001-03-26 アルコン ラボラトリーズ,インコーポレイテッド 有力なカルシウム拮抗活性および酸化防止活性の両方を有する化合物および細胞保護剤としてのその使用
NZ589492A (en) * 2008-06-02 2012-06-29 Cipla Ltd Processes for the synthesis of levocetirizine and intermediates for use therein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2709169A (en) * 1955-05-24 X c chs
US3051710A (en) * 1959-12-21 1962-08-28 Lakeside Lab Inc Glycolic acid amide derivatives of piperazine and use thereof

Also Published As

Publication number Publication date
SE396385B (sv) 1977-09-19
BG20596A3 (no) 1975-12-05
AR196936A1 (es) 1974-02-28
FI55656B (fi) 1979-05-31
ES415466A1 (es) 1976-05-16
SU577995A3 (ru) 1977-10-25
AT331252B (de) 1976-08-10
IL42384A (en) 1976-12-31
FR2186265B1 (no) 1976-03-05
FI55656C (fi) 1979-09-10
RO68379A (ro) 1981-11-24
CS178429B2 (no) 1977-09-15
AT331802B (de) 1976-08-25
DK139751C (da) 1979-09-17
RO62900A (ro) 1982-10-26
AU470393B2 (en) 1976-03-11
AT331801B (de) 1976-08-25
CH594651A5 (no) 1978-01-13
DK139751B (da) 1979-04-09
AU5634373A (en) 1974-12-05
RO68378A (ro) 1982-02-01
DD106644A5 (no) 1974-06-20
HU165312B (no) 1974-08-28
AR204987A1 (es) 1976-03-31
AR194688A1 (es) 1973-07-31
CA980347A (en) 1975-12-23
EG11434A (en) 1977-09-30
NO138026B (no) 1978-03-06
ATA483173A (de) 1975-12-15
PL91050B1 (no) 1977-02-28
SU530644A3 (ru) 1976-09-30
ES415465A1 (es) 1976-05-16
CH574949A5 (no) 1976-04-30
PL94759B1 (pl) 1977-08-31
US3868377A (en) 1975-02-25
AR200764A1 (es) 1974-12-13
FR2186265A1 (no) 1974-01-11
SU507238A3 (ru) 1976-03-15
PH9485A (en) 1976-01-08
CS178430B2 (no) 1977-09-15
CS182234B2 (en) 1978-04-28
BG20595A3 (no) 1975-12-05
ES415464A1 (es) 1976-05-01
AR201001A1 (es) 1975-02-06
CH579064A5 (no) 1976-08-31
ATA483273A (de) 1975-11-15
NL7306771A (no) 1973-12-04
SU508196A3 (ru) 1976-03-25
CH593959A5 (no) 1977-12-30
PL97129B1 (pl) 1978-02-28
GB1386916A (en) 1975-03-12
IL42384A0 (en) 1973-07-30
IE37717B1 (en) 1977-09-28
CS182248B2 (en) 1978-04-28
IE37717L (en) 1973-12-02
JPS4948687A (no) 1974-05-11
BG20371A3 (no) 1975-11-05
ATA483073A (de) 1975-12-15

Similar Documents

Publication Publication Date Title
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NO793013L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater
NO138335C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO137440C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pleuromutiliner
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO142033C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler
NO137782C (no) Analogifremgangsmaate for fremstilling av nye farmakologisk aktive amino-fenyl-etanolaminer
NO137899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO140596C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktive hydroksyalkylxantiner
NO138026C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner
NO139088C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner
NO138063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO137151C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive ortiotropin-peptider
NO138025C (no) Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler
NO138251C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer
NO139050C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater
NO140299C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner
NO137695C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser
SE403612B (sv) Analogiforfarande for framstellning av antibakteriellt aktiva hexametylen-bis-biguanider